GENECENTRIC THERAPEUTICS

GeneCentric Therapeutics engages in developing and commercializing molecular diagnostic tests for oncologists and patients. The company currently has two unique platform technologies including The Lung Subtype Platform (LSP) stratifies lung cancer patients into subtypes, which are important for appropriate therapeutic selection. The first application of LSP was licensed to and independently developed by Laboratory Corporation of America Holdings (“LabCorp”) and is now available through its s... pecialty testing business, Integrated Oncology, as HistoPlusSM: Lung Cancer. Its second platform technology is the Hypoxia Signature which has the potential to identify patients that respond to anti-angiogenesis therapies. GeneCentric utilizes a unique partnership model to translate important cancer discoveries into clinically adopted diagnostics for pathologists, clinicians, and, most importantly, patients. The company was incorporated in 2011 and is based in Durham, North Carolina.

#SimilarOrganizations #People #Financial #Website #More

GENECENTRIC THERAPEUTICS

Social Links:

Twitter

Industry:

Biotechnology Health Care Health Diagnostics

Founded:

2011-01-01

Address:

Durham, North Carolina, United States

Country:

United States

Website Url:

http://www.genecentric.com

Total Employee:

11+

Status:

Active

Contact:

919-215-5962

Email Addresses:

[email protected]

Total Funding:

38.61 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving Wordpress Plugins